Cover image of the article: Is the aspartate transaminase to platelet ratio index adequate for the assessment of liver fibrosis in patients with chronic liver disease?

Image Credit:Hepat Mon

Is the aspartate transaminase to platelet ratio index adequate for the assessment of liver fibrosis in patients with chronic liver disease?

Authors

Hadi ParsianHadi Parsian ORCID1,*
1Department of Biochemistry and Biophysics, Babol University of Medical Sciences, hadiparsian@yahoo.com, IR Iran
*Corresponding Author: Department of Biochemistry and Biophysics, Babol University of Medical Sciences, hadiparsian@yahoo.com, IR Iran. Tel: +98-1112190569. Fax: +98-1112190569. Email: hadiparsian@yahoo.com

Hepatitis Monthly:Vol. 11, issue 5; 380-381
Published online:May 31, 2011
Article type:Letter
Received:Mar 27, 2011
Accepted:Apr 13, 2011
How to Cite:Parsian H. Is the aspartate transaminase to platelet ratio index adequate for the assessment of liver fibrosis in patients with chronic liver disease?. Hepat Mon. 2011;11(5):. doi:

Abstract

This article does not have abstract.

Full Text

Full text is available in PDF

Copyright

© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Jul
2011
Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Omid Abedian,
Abolghasem Ajami,
Farshideh Abedian,
Araz Mirabi,
Ali-Reza Khalilian,
Hana Saffar
,et al.

Abedian O, Ajami A, Abedian F, Mirabi A, Khalilian A, et al. Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI). Hepat Mon. 2012;12(5):. doi: https://doi.org/10.5812/hepatmon.6035

31
Jul
2011
Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Michael Adler

Adler M. Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI). Hepat Mon. 2011;11(7):. doi:

31
Jul
2011
Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Seyed Mohammadmehdi Hosseini Moghaddam

Hosseini Moghaddam SM. Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI). Hepat Mon. 2011;11(8):. doi: https://doi.org/10.5812/kowsar.1735143X.770

31
Jul
2011
Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI)

Melda Ulusoy,
Gulgun Akkoclu,
Ayhan Gozaydin,
Sukran Kose

Ulusoy M, Akkoclu G, Gozaydin A, Kose S. Noninvasive assessment of liver fibrosis with aspartate transaminase to platelet ratio index (APRI). Hepat Mon. 2010;10(3):. doi:

31
Jul
2011
Aspartate aminotransferase to platelet ratio index for the assessment of liver fibrosis severity in patients with chronic hepatitis

Aspartate aminotransferase to platelet ratio index for the assessment of liver fibrosis severity in patients with chronic hepatitis

Roxana Sirli,
Ioan Sporea

Sirli R, Sporea I. Aspartate aminotransferase to platelet ratio index for the assessment of liver fibrosis severity in patients with chronic hepatitis. Hepat Mon. 2011;11(7):. doi:

More by these authors

Hadi ParsianPubMedScholar
Share
Cited by
Metrics